However, another analysis found improved overall survival when ICIs were given within 30 days of stereotactic radiosurgery (SRS), especially in PD-L1 positive NSCLC patients (40 months vs. 8 months in the control group) [47]. Here, CD274 is linked to non-small cell lung carcinoma.